SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001096906-11-003063
Filing Date
2011-12-08
Accepted
2011-12-08 14:15:31
Documents
2
Period of Report
2011-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. FORM 8-K DECEMBER 5, 2011 axn8k20111205.htm 8-K 24621
2 PRESS RELEASE ex99-1.htm EX-99.1 10439
  Complete submission text file 0001096906-11-003063.txt   36691
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

IRS No.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-32674 | Film No.: 111250552
SIC: 2834 Pharmaceutical Preparations